Navigation Links
Digital Mammography and Clinical Review Display Units Energising the European Markets for Medical Imaging Display Monitors, Finds Frost & Sullivan
Date:6/17/2009

LONDON, June 17 /PRNewswire/ -- Diagnostic display monitors experienced slow growth in 2007 due to picture archiving and communication system (PACS) installations across radiology departments of European hospitals having reached saturation. However, favourable regulations mandating the sales of 5MP displays for digital mammography have ensured high-volume sales in several European countries. The increasing demand for clinical review display monitors from private practitioners has also ensured very high growth rates for medical imaging display monitors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan http://www.medicalimaging.frost.com), European Medical Imaging Display Monitors Market, finds that the market earned revenues of $207.2 million in 2007 and estimates this to reach $520.4 million in 2014. The following segments are covered in this research: acquisition display, diagnostic display, surgical display, clinical review display and mammography display.

If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Katja Feick, Corporate Communications, at katja.feick@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, a brochure will be sent to you by e-mail.

"A favourable reimbursement scenario combined with an improving regulatory environment for digital mammography has resulted in the large volume sales of 5MP mammography display monitors," notes Frost & Sullivan Research Analyst Krishanu Bhattacharjee. "PACS installations are set to expand beyond their conventional deployment in radiology departments with the market for diagnostic display monitors poised to grow steadily in the cardiology and surgical departments of European hospitals."

The mounting demand to include colour images in the daily workflow of radiologists has supported sustained market growth in the past two years. Display manufacturers will also benefit from the steady increase in PACS installations across cardiology departments.

The sales of acquisition displays suffered in 2007 due to most imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI) reaching maturity. Market growth has also been adversely affected by the saturation in radiology PACS installations in European hospitals. The lack of stringent standards and mandates will affect volume sales of clinical review display monitors in the coming years.

"A cost-cutting spree amongst European hospitals has directly affected the sale of imaging equipment, hampering the sales of acquisition display monitors attached to these systems," remarks Bhattacharjee. "Revenue channels from PACS installations have also started closing down owing to saturation of PACS in large and medium-size hospitals. With hospitals hesitating to invest in high definition displays for surgical suites, market penetration of surgical displays is projected to be low in the near future."

Vendors should target small and medium-sized hospitals where PACS installations are yet to be made in order to ensure sustained revenue generation from slow growing market segments such as diagnostic displays. They also need to establish efficient distribution channels to be able to reach private practitioners and boost volume sales of clinical review display monitors.

"Display manufacturers will have to come up with competitive promotional offers for surgical display monitors to encourage higher adoption rates," advises Bhattacharjee. "Also, as hospitals reduce their outlay on display monitors and other large imaging modalities, vendors need to develop innovative post processing and 3D image reconstruction software. This will enable sustained revenue generation."

European Medical Imaging Display Monitors Market is part of the Medical Imaging Growth Partnership Service programme, which also includes research in the following markets: Eastern European Ultrasound Market, European Medical Imaging Equipment Market for Cardiology Applications and Eastern European Medical Imaging Modalities. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

European Medical Imaging Display Monitors Market

M2B4

    Contact:
    Katja Feick
    Corporate Communications - Europe
    P: +49 (0) 69 7703343
    E: katja.feick@frost.com
   http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Digital Healthcare Wins FDA Approval for Retasure
2. Digital Healthcare Wins FDA Approval for Retasure
3. Astra Tech Acquires Innovative Dental Digital Technology Company
4. Digital Info Security Company and DGF MedServ, Inc. Announce Intent to Partner in Marketing DGIF IT Solutions to Medical Industry
5. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
6. Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director
7. Siemens Rolls Out Its First Mobile Digital Mammography System in the U.S.
8. SMRT Architects and Engineers Selected to Design New $115M Digital X-Ray Manufacturing Facility for GE Healthcare
9. Digital Healthcare Announces Appointment of Dr. Suber Huang as Medical Director
10. Keeneland Scales Eklin Digital Repository(TM) to 32 Medical Image Review Workstations
11. Radlink Introduces New Family of Digital Imaging Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... August 21, 2017 , ... Marathon ... all over the country. , Outdoor running increases exposure to ultraviolet radiation, a ... increased risk of melanoma, and only half may be adequately protecting themselves with ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... San Diego ... ) health care reform plan, has announced his candidacy for the 52nd Congressional District ... and shared in America’s Promise. Coming to this country at age eleven after suffering ...
(Date:8/20/2017)... ... ... State Farm Neighborhood Assist® has named The Southern Maryland Team Anti-Bullying Program ... initiative wins, Gals Lead – Dream Queen Foundation’s signature teen girl program to help ... Calvert and Charles Counties. The program could potentially impact nearly 17,500 female students (49.4 ...
(Date:8/19/2017)... MD (PRWEB) , ... August 18, 2017 , ... ... and Drug Administration Reauthorization Act of 2017, legislation that provides for greater public ... mild to moderate hearing loss to access OTC hearing aids without being seen ...
(Date:8/19/2017)... ... August 19, 2017 , ... Parker at Stonegate, an assisted ... passionate employees, caregivers, volunteers, thought leaders, researchers, educators and partners leading the way ... time to refresh the carpeting with the goal of maintaining the same precise ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO), ... Michigan residents. Naloxone is available ... retail pharmacy, G-3320 Beecher Road. ... and Drug Administration, is intended to block or reverse ... and loss of consciousness. The medication is often carried ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... DUBLIN, Aug. 8, 2017   ... $3.12 diluted (GAAP) loss per share from continuing operations ... Products revenues increased 16 percent to $110 million ... increased 27 percent to $161 million ... (EPS) from continuing operations increased 8 percent to $0.93 ...
Breaking Medicine Technology: